The global blood preparation market is expected to reach $58.69 billion by 2022, driven by growing demand for blood transfusions and rising prevalence of blood-related disorders. Key factors fueling market growth include an increasing elderly population, commercialization of drugs in the product pipeline, and presence of advanced technologies for blood preparation and storage. The market is segmented by product, anti-thrombotic/anticoagulant type, and application. By product, plasma and blood components represent the largest segments. Geographically, North America accounts for the largest share currently but Asia Pacific is expected to experience the fastest growth over the forecast period.

1. Blood preparation Market By Product (Whole Blood,
Plasma, Blood Components), By Anti-thrombotic And
Anticoagulant Type (Platelet Aggregation Inhibitors), By
Application (Thrombocytosis, Pulmonary Embolism) Is
Expected To Reach USD 58.69 Billion By 2022
Global Blood preparation Market is expected to reach USD 58.69 billion by 2022, according to a
new study by Grand View Research, Inc. Growing worldwide demand for transfusion of blood
and its components and increasing prevalence of blood-related disorders are expected to fuel the
growth of the blood preparation market over the forecast period. The worldwide prevalence of
thrombocytosis-associated disorders is steeply increasing. According to the Center for Disease
control and Prevention (CDC), one to two people per 1,000 are affected by DVT/PE in the U.S.
each year, and 60,000-100,000 Americans die due to DVT/PE. Commercialization of drugs
currently in the pipeline, introduction of new oral anticoagulants, and the presence of large
untapped opportunities are expected to boost product demand by triggering the incidence rates of
target diseases.
Anticoagulants was the largest product segment in 2014 owing to, the increasing R&D aimed at
the the development of novel prophylactic and therapeutic drugs. Re-launch of some key drug
products such as Urokinase in North America is most likely expected to boost market growth
over the forecast period. Microbix Biosystems Inc. acquired Urokinase from Abbott Laboratories
(Abbokinase) to relaunch it as Kinelytic in the U.S. The drug is under regulatory approval and is
expected to be relaunched in the middle of 2015 in the U.S.

2. View summary of this report @ http://www.grandviewresearch.com/industry-
analysis/blood-preparation-market
Global blood preparation market share, by product, 2012-2022 (USD Million)
Table of Content
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
2.1 Blood Preparation Market - Industry Snapshot & Key Buying Criteria, 2012 -
2022
Chapter 3 Blood Preparation Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects
3.3 Blood preparation: Market dynamics
3.3.1 Market driver analysis
3.3.1.1 Growing demand for whole blood and blood components transfusion

3. 3.3.1.2 Increasing usage of plasma in pharmaceutical industry
3.3.1.3 Increasing Geriatric population
3.3.1.4 Presence of a strong product pipeline portfolio
3.3.1.5 Presence of advanced technology for blood preparation and storage
3.3.2 Market restraint analysis
3.3.2.1 Risk of blood transmitted diseases and growing blood subsitutes
3.4 Key Opportunities Prioritized
3.5 Industry analysis - Porter’s
3.6 Blood preparation - PESTEL Analysis
3.7 Government Initiatives and Trends
3.8 Blood Preparation - Pipeline and New Product Development Analysis
Chapter 4 Blood Preparation Product Outlook
4.1 Blood preparation market share by product, 2014 & 2022
4.2 Whole blood market
4.2.1 Whole blood market, 2012 - 2022 (USD Million)
4.2.2 Red cells
4.2.2.1 Red cells market, 2012 - 2022 (USD Million)
4.2.3 Granulocytes
4.2.3.1 Granulocytes market, 2012 - 2022 (USD Million)
4.2.4 Plasma
4.2.4.1 Plasma market, 2012 - 2022 (USD Million)
4.2.5 Platelets
4.2.5.1 Platelets market, 2012 - 2022 (USD Million)
4.3 Blood components market
4.3.1 Blood components market, 2012 - 2022 (USD Million)
4.3.2 Whole blood components market, 2012 - 2022 (USD Million)
4.3.3 Packed red cells
4.3.3.1 Packed red cells market, 2012 - 2022 (USD Million)
4.3.4 Leukocyte reduced red blood cells
4.3.4.1 Leukocyte reduced red blood cells market, 2012 - 2022 (USD Million)
4.3.5 Frozen plasma
4.3.5.1 Frozen plasma market, 2012 - 2022 (USD Million)
4.3.6 Platelet concentrate
4.3.6.1 Platelet concentrate market, 2012 - 2022 (USD Million)
4.3.7 Cryoprecipitate
4.3.7.1 Cryoprecipitate market, 2012 - 2022 (USD Million)
4.4 Blood derivatives
4.4.1 Blood derivatives market, 2012 - 2022 (USD Million)
Chapter 5 Anti-thrombotic And Anticoagulants Type Outlook
5.1 Anti-thrombotic and anticoagulants market share by type, 2014 & 2022
5.2 Platelet Aggregation Inhibitors market
5.2.1 Platelet aggregation inhibitors market, 2012 - 2022 (USD Million)
5.2.2 Glycoprotein inhibitors

4. 5.2.2.1 Glycoprotein inhibitors market, 2012 - 2022 (USD Million)
5.2.3 COX inhibitors
5.2.3.1 COX inhibitors market, 2012 - 2022 (USD Million)
5.2.4 ADP antagonists
5.2.4.1 ADP antagonists market, 2012 - 2022 (USD Million)
5.2.5 Phosphodiesterase inhibitors
5.2.5.1 Phosphodiesterase inhibitors market, 2012 - 2022 (USD Million)
5.2.6 Others market, 2012 - 2022 (USD Million)
5.3 Fibrinolytics market
5.3.1 Fibrinolytics market, 2012 - 2022 (USD Million)
5.3.2 Tissue Plasminogen Activator (tPA)
5.3.2.1 Tissue Plasminogen Activator (tPA) market, 2012 - 2022 (USD Million)
5.3.3 Streptokinase
5.3.3.1 Streptokinase market, 2012 - 2022 (USD Million)
5.3.4 Urokinase
5.3.4.1 Urokinase market, 2012 - 2022 (USD Million)
5.4 Anticoagulants
5.4.1 Anticoagulants market, 2012 - 2022 (USD Million)
5.4.2 Heparins
5.4.2.1 Heparins market, 2012 - 2022 (USD Million)
5.4.2.2 Unfractionated heparin market, 2012 - 2022 (USD Million)
5.4.2.3 Low Molecular Weight Heparin (LMWH) market, 2012 - 2022 (USD
Million)
5.4.2.4 Ultra-low Molecular Weight Heparin(ULMWH) market, 2012 - 2022
(USD Million)
5.4.3 Vitamin K antagonists
5.4.3.1 Vitamin K antagonists market, 2012 - 2022 (USD Million)
5.4.4 Direct thrombin inhibitors
5.4.4.1 Direct thrombin inhibitors market, 2012 - 2022 (USD Million)
5.4.5 Direct factor Xa inhibitors
5.4.5.1 Direct factor Xa inhibitors market, 2012 - 2022 (USD Million)
Chapter 6 Anti-thrombotic And Anticoagulants Application Outlook
6.1 Anti-thrombotic and anticoagulants market share by application, 2014 & 2022
6.2 Thrombocytosis
6.2.1 Thrombocytosis market, 2012 - 2022 (USD Million)
6.3 Pulmonary embolism
6.3.1 Pulmonary embolism market, 2012 - 2022 (USD Million)
6.4 Renal impairment
6.4.1 Renal impairment market, 2012 - 2022 (USD Million)
6.5 Angina blood vessel complications
6.5.1 Angina blood vessel complications market, 2012 - 2022 (USD Million)
6.6 Others
6.6.1 Others market, 2012 - 2022 (USD Million)

5. Chapter 7 Blood preparation Regional Outlook
7.1 Blood preparation market share, by region, 2014 & 2022
7.2 North America
7.2.1 North America Blood preparation market, 2012 - 2022 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. market, by product, 2012 - 2022 (USD Million)
7.2.4 Canada
7.2.4.1 Canada market, by product, 2012 - 2022 (USD Million)
7.3 Europe
7.3.1 Europe blood preparation market, 2012 - 2022 (USD Million)
7.3.2 Germany
7.3.2.1 Germany market, by product, 2012 - 2022 (USD Million)
7.3.4 France
7.3.4.1 France market, by product, 2012 - 2022 (USD Million)
7.3.6 UK
7.3.6.1 UK market, by product, 2012 - 2022 (USD Million)
7.3.8 Italy
7.3.8.1 Italy market, by product, 2012 - 2022 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific blood preparation market, 2012 - 2022 (USD Million)
7.4.2 Japan
7.4.2.1 Japan market, by product, 2012 - 2022 (USD Million)
7.4.4 China
7.4.4.1 China market, by product, 2012 - 2022 (USD Million)
7.5 Latin America
7.5.1 Latin America blood preparation market, 2012 - 2022 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil market, by product, 2012 - 2022 (USD Million)
7.5.4 Mexico
7.5.4.1 Mexico market, by product, 2012 - 2022 (USD Million)
7.6 MEA
7.6.1 MEA blood preparation market, 2012 - 2022 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa market, by product, 2012 - 2022 (USD Million)
Chapter 8 Anti-thrombotic And Anticoagulants Regional Outlook
8.1 Anti-thrombotic and anticoagulants market share, by region, 2014 & 2022
8.2 North America anti-thrombotic and anticoagulants market, 2012 - 2022 (USD
Million)
8.2.1 U.S. anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.2.2 Canada anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.3 Europe anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)

6. 8.3.1 Germany anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.3.2 France anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.3.3 UK anti-thrombotic and anticoagulants market, by product, 2012 - 2022 (USD
Million)
8.3.4 Italy anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.4 Asia Pacific anti-thrombotic and anticoagulants market, 2012 - 2022 (USD
Million)
8.4.1 Japan anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.4.2 China anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.5 Latin America anti-thrombotic and anticoagulants market, 2012 - 2022 (USD
Million)
8.5.1 Brazil anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.5.2 Mexico anti-thrombotic and anticoagulants market, by product, 2012 - 2022
(USD Million)
8.6 MEA anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
8.6.1 South Africa anti-thrombotic and anticoagulants market, by product, 2012 -
2022 (USD Million)
Chapter 9 Competitive Landscape
9.1 GlaxoSmithKline PLC
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Pfizer Inc.
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Baxter Healthcare Corp.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Shandong East Chemical Industry Co.
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking

7. 9.5 Bristol-Myers Squibb Co.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Leo Pharma Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Sanofi Aventis
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.7.4 Strategic Initiatives
9.8 Hisunny Chemical Co
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.9 AstraZeneca Co
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Celgene Corp.
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
Browse full report @ http://www.grandviewresearch.com/industry-analysis/blood-
preparation-market
List of Tables
TABLE 1 Global blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 2 Global blood preparation market, by application, 2012 - 2022 (USD Million)
TABLE 3 Global anti-thrombotic and anticoagulants, by type 2012 - 2022 (USD Million)
TABLE 4 Global blood preparation market, by Region, (USD Billion), 2012 - 2022
TABLE 5 Blood Preparation market - Key market driver analysis

8. TABLE 6 Major plasma proteins and their concentration in plasma
TABLE 7 Blood preparation - Key market restraint analysis
TABLE 8 Pipeline and new product development analysis
TABLE 9 North America blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 10 North America whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 11 North America blood components market, by product, 2012 - 2022 (USD Million)
TABLE 12 U.S. blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 13 U.S. whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 14 U.S. blood components market, by product, 2012 - 2022 (USD Million)
TABLE 15 Canada blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 16 Canada whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 17 Canada blood components market, by product, 2012 - 2022 (USD Million)
TABLE 18 Europe blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 19 Europe whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 20 Europe blood components market, by product, 2012 - 2022 (USD Million)
TABLE 21 Germany blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 22 Germany whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 23 Germany blood components market, by product, 2012 - 2022 (USD Million)
TABLE 24 France blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 25 France whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 26 France blood components market, by product, 2012 - 2022 (USD Million)
TABLE 27 UK blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 28 UK whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 29 UK blood components market, by product, 2012 - 2022 (USD Million)
TABLE 30 Italy blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 31 Italy whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 32 Italy blood components market, by product, 2012 - 2022 (USD Million)
TABLE 33 Asia Pacific blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 34 Asia Pacific whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 35 Asia Pacific blood components market, by product, 2012 - 2022 (USD Million)
TABLE 36 Japan blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 37 Japan whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 38 Japan blood components market, by product, 2012 - 2022 (USD Million)
TABLE 39 China blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 40 China whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 41 China blood components market, by product, 2012 - 2022 (USD Million)
TABLE 42 Latin America blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 43 Latin America whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 44 Latin America blood components market, by product, 2012 - 2022 (USD Million)
TABLE 45 Brazil blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 46 Brazil whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 47 Brazil blood components market, by product, 2012 - 2022 (USD Million)
TABLE 48 Mexico blood preparation market, by product, 2012 - 2022 (USD Million)

9. TABLE 49 Mexico whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 50 Mexico blood components market, by product, 2012 - 2022 (USD Million)
TABLE 51 MEA blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 52 MEA whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 53 MEA blood components market, by product, 2012 - 2022 (USD Million)
TABLE 54 South Africa blood preparation market, by product, 2012 - 2022 (USD Million)
TABLE 55 South Africa whole blood market, by product, 2012 - 2022 (USD Million)
TABLE 56 South Africa blood components market, by product, 2012 - 2022 (USD Million)
TABLE 57 North America anti-thrombotic and anticoagulants market, by type, 2012 - 2022
(USD Million)
TABLE 58 North America platelet aggregation inhibitors market, by type, 2012 - 2022 (USD
Million)
TABLE 59 North America fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 60 North America anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 61 North America heparin market, by type, 2012 - 2022 (USD Million)
TABLE 62 North America anti-thrombotic and anticoagulants market, by application, 2012 -
2022 (USD Million)
TABLE 63 U.S. anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 64 U.S. platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 65 U.S. fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 66 U.S. anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 67 U.S. heparin market, by type, 2012 - 2022 (USD Million)
TABLE 68 U.S. anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 69 Canada anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 70 Canada platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 71 Canada fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 72 Canada anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 73 Canada heparin market, by type, 2012 - 2022 (USD Million)
TABLE 74 U.S. anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 75 Europe anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 76 Europe platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 77 Europe fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 78 Europe anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 79 Europe heparin market, by type, 2012 - 2022 (USD Million)
TABLE 80 Europe anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 81 Germany anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 82 Germany platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)

10. TABLE 83 Germany fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 84 Germany anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 85 Germany heparin market, by type, 2012 - 2022 (USD Million)
TABLE 86 Germany anti-thrombotic and anticoagulants market, by application, 2012 - 2022
(USD Million)
TABLE 87 France anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 88 France platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 89 France fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 90 France anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 91 France heparin market, by type, 2012 - 2022 (USD Million)
TABLE 92 France anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 93 UK anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 94 UK platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 95 UK fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 96 UK anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 97 UK heparin market, by type, 2012 - 2022 (USD Million)
TABLE 98 UK anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 99 Italy anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 100 Italy platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 101 Italy fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 102 Italy anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 103 Italy heparin market, by type, 2012 - 2022 (USD Million)
TABLE 104 Italy anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 105 Asia Pacific anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 106 Asia Pacific platelet aggregation inhibitors market, by type, 2012 - 2022 (USD
Million)
TABLE 107 Asia Pacific fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 108 Asia Pacific anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 109 Asia Pacific heparin market, by type, 2012 - 2022 (USD Million)
TABLE 110 Asia Pacific anti-thrombotic and anticoagulants market, by application, 2012 - 2022
(USD Million)
TABLE 111 Japan anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 112 Japan platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 113 Japan fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 114 Japan anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 115 Japan heparin market, by type, 2012 - 2022 (USD Million)

11. TABLE 116 Japan anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 117 China anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 118 China platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 119 China fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 120 China anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 121 China heparin market, by type, 2012 - 2022 (USD Million)
TABLE 122 China anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 123 Latin America anti-thrombotic and anticoagulants market, by type, 2012 - 2022
(USD Million)
TABLE 124 Latin America platelet aggregation inhibitors market, by type, 2012 - 2022 (USD
Million)
TABLE 125 Latin America fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 126 Latin America anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 127 Latin America heparin market, by type, 2012 - 2022 (USD Million)
TABLE 128 Latin America anti-thrombotic and anticoagulants market, by application, 2012 -
2022 (USD Million)
TABLE 129 Brazil anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 130 Brazil platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 131 Brazil fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 132 Brazil anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 133 Brazil heparin market, by type, 2012 - 2022 (USD Million)
TABLE 134 Brazil anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)
TABLE 135 Mexico anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 136 Mexico platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 137 Mexico fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 138 Mexico anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 139 Mexico heparin market, by type, 2012 - 2022 (USD Million)
TABLE 140 Mexico anti-thrombotic and anticoagulants market, by application, 2012 - 2022
(USD Million)
TABLE 141 MEA anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 142 MEA platelet aggregation inhibitors market, by type, 2012 - 2022 (USD Million)
TABLE 143 MEA market, by type, 2012 - 2022 (USD Million)
TABLE 144 MEA anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 145 MEA heparin market, by type, 2012 - 2022 (USD Million)
TABLE 146 MEA anti-thrombotic and anticoagulants market, by application, 2012 - 2022 (USD
Million)

12. TABLE 147 South Africa anti-thrombotic and anticoagulants market, by type, 2012 - 2022 (USD
Million)
TABLE 148 South Africa platelet aggregation inhibitors market, by type, 2012 - 2022 (USD
Million)
TABLE 149 South Africa fibrinolytics market, by type, 2012 - 2022 (USD Million)
TABLE 150 South Africa anticoagulants market, by type, 2012 - 2022 (USD Million)
TABLE 151 South Africa heparin market, by type, 2012 - 2022 (USD Million)
TABLE 152 South Africa anti-thrombotic and anticoagulants market, by application, 2012 -
2022 (USD Million)
For More Information visit http://www.grandviewresearch.com/industry-analysis/blood-
preparation-market
List of Figures
FIG. 1 Blood preparation market segmentation
FIG. 2 Global blood preparation market, 2012 - 2022 (USD Million)
FIG. 3 Blood preparation: Market dynamics
FIG. 4 Red blood cell use by hospital service in 2011
FIG. 5 Platelet use by hospital service in 2011
FIG. 6 Global plasma fraction demand in 2010
FIG. 7 Global population growth, by age-group, 2012 - 2020 (Million)
FIG. 8 Population aged 65+ as percentage of total population, 2010 - 2030 (%)
FIG. 9 Key opportunities prioritized
FIG. 10 Blood preparation market - Porter’s analysis
FIG. 11 Blood preparation market - PESTEL analysis
FIG. 12 Blood preparation market share by product, 2014 & 2022
FIG. 13 Whole blood market, 2012 - 2022 (USD Million)
FIG. 14 Red cells market, 2012 - 2022 (USD Million)
FIG. 15 Granulocytes market, 2012 - 2022 (USD Million)
FIG. 16 Plasma market, 2012 - 2022 (USD Million)
FIG. 17 Platelets market, 2012 - 2022 (USD Million)
FIG. 18 Blood components market, 2012 - 2022 (USD Million)
FIG. 19 Whole blood components market, 2012 - 2022 (USD Million)
FIG. 20 Packed red cells market, 2012 - 2022 (USD Million)
FIG. 21 Leukocyte reduced red blood cells market, 2012 - 2022 (USD Million)
FIG. 22 Frozen plasma market, 2012 - 2022 (USD Million)
FIG. 23 Platelet concentrate market, 2012 - 2022 (USD Million)

13. FIG. 24 Cryoprecipitate market, 2012 - 2022 (USD Million)
FIG. 25 Blood derivatives market, 2012 - 2022 (USD Million)
FIG. 26 Anti-thrombotic and anticoagulants market share by type, 2014 & 2022
FIG. 27 Platelet aggregation inhibitors market, 2012 - 2022 (USD Million)
FIG. 28 Glycoprotein inhibitors market, 2012 - 2022 (USD Million)
FIG. 29 COX inhibitors market, 2012 - 2022 (USD Million)
FIG. 30 ADP antagonists market, 2012 - 2022 (USD Million)
FIG. 31 Phosphodiesterase inhibitors market, 2012 - 2022 (USD Million)
FIG. 32 Others market, 2012 - 2022 (USD Million)
FIG. 33 Fibrinolytics market, 2012 - 2022 (USD Million)
FIG. 34 Tissue Plasminogen Activator (tPA) market, 2012 - 2022 (USD Million)
FIG. 35 Streptokinase market, 2012 - 2022 (USD Million)
FIG. 36 Urokinase market, 2012 - 2022 (USD Million)
FIG. 37 Anticoagulants market, 2012 - 2022 (USD Million)
FIG. 38 Heparins market, 2012 - 2022 (USD Million)
FIG. 39 Unfractionated heparin market, 2012 - 2022 (USD Million)
FIG. 40 Low Molecular Weight Heparin (LMWH) market, 2012 - 2022 (USD Million)
FIG. 41 Ultra-low Molecular Weight Heparin (ULMWH) market, 2012 - 2022 (USD Million)
FIG. 42 Vitamin K antagonists market, 2012 - 2022 (USD Million)
FIG. 43 Direct thrombin inhibitors market, 2012 - 2022 (USD Million)
FIG. 44 Direct factor Xa inhibitors market, 2012 - 2022 (USD Million)
FIG. 45 Anti-thrombotic and anticoagulants market share by application, 2014 & 2022
FIG. 46 Thrombocytosis market, 2012 - 2022 (USD Million)
FIG. 47 Pulmonary embolism market, 2012 - 2022 (USD Million)
FIG. 48 Renal impairment market, 2012 - 2022 (USD Million)
FIG. 49 Angina blood vessel complications market, 2012 - 2022 (USD Million)
FIG. 50 Others market, 2012 - 2022 (USD Million)
FIG. 51 Blood preparation market share, by region, 2014 & 2022
FIG. 52 North America Blood preparation market, 2012 - 2022 (USD Million)
FIG. 53 U.S. Blood preparation market, 2012 - 2022 (USD Million)
FIG. 54 Canada blood preparation market, 2012 - 2022 (USD Million)
FIG. 55 Europe blood preparation market, 2012 - 2022 (USD Million)
FIG. 56 Germany blood preparation market, 2012 - 2022 (USD Million)
FIG. 57 France blood preparation market, 2012 - 2022 (USD Million)
FIG. 58 UK blood preparation market, 2012 - 2022 (USD Million)
FIG. 59 Italy blood preparation market, 2012 - 2022 (USD Million)
FIG. 60 Asia Pacific blood preparation market, 2012 - 2022 (USD Million)
FIG. 61 Japan blood preparation market, 2012 - 2022 (USD Million)
FIG. 62 China blood preparation market, 2012 - 2022 (USD Million)
FIG. 63 Latin America blood preparation market, 2012 - 2022 (USD Million)
FIG. 64 Brazil blood preparation market, 2012 - 2022 (USD Million)
FIG. 65 Mexico blood preparation market, 2012 - 2022 (USD Million)
FIG. 66 MEA blood preparation market, 2012 - 2022 (USD Million)

14. FIG. 67 South Africa blood preparation market, 2012 - 2022 (USD Million)
FIG. 68 Anti-thrombotic and anticoagulants market share, by region, 2014 & 2022
FIG. 69 North America anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 70 U.S. anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 71 Canada anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 72 Europe anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 73 Germany anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 74 France anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 75 UK anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 76 Italy anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 77 Asia Pacific anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 78 Japan anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 79 China anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 80 Latin America anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 81 Brazil anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 82 Mexico anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 83 MEA anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
FIG. 84 South Africa anti-thrombotic and anticoagulants market, 2012 - 2022 (USD Million)
Further key findings from the study suggest:
 The blood derivates market was valued at over 13.0 billion in 2014 and is expected grow
at a lucrative rate from 2015 to 2022 owing to, the increasing transfusion needs of blood
and its components. Increasing number of R&D pertaining to the development of blood-
derived medicines and expected commercialization of new drugs are also expected to
serve as high impact rendering drivers.
 The direct factor Xa inhibitors market is identified as the most lucrative segment on
account of the introduction of new oral products such as Xarelto, Savaysa, and Eliquis,
targeting unmet medical needs.
 The North American blood preparation market was the largest in 2014. The presence of
sophisticated healthcare infrastructure and high patient awareness levels coupled with
relatively higher healthcare expenditure levels in the region are some factors attributing
to its market position.
 Asia Pacific is anticipated to witness high future growth over the forecast period, owing
to the presence of favorable government initiatives, sophisticated healthcare
infrastructure in Japan and Australia and large untapped opportunities in the emerging
markets of China and India.
 Key players of the blood preparation market include GlaxoSmithKline PLC, Pfizer Inc.,
Baxter Healthcare Corp., Bristol-Myers Squibb Co., Leo Pharma Inc., Sanofi Aventis,
AstraZeneca Co., and Celgene Corp.

15. Request free sample of this Report @ http://www.grandviewresearch.com/industry-
analysis/blood-preparation-market/request
For the purpose of this study, Grand View Research has segmented the global blood preparation
market on the basis of products, anti-thrombotics and anticoagulant type, anti-thrombotics and
anticoagulant application, and region:
Global Blood preparation Market Product Outlook (Revenue, USD Million) 2012 – 2022
 Whole Blood
 Red Cells
 Granulocytes
 Plasma
 Platelets
 Blood Components
 Whole Blood Components
 Packed Red Cells
 Leukocyte Reduced Red Blood Cells
 Frozen Plasma
 Platelet Concentrate
 Blood Derivatives
Global Blood Preparation Market Anti-Thrombotic and Anticoagulants Type Outlook
(Revenue, USD Million, 2012 – 2022)
 Platelet Aggregation Inhibitors
 Glycoprotein Inhibitors
 COX Inhibitors
 ADP Antagonists
 Phosphodiesterase Inhibitors
 Fibrinolytics
 Tissue Plasminogen Activator (tPA)
 Streptokinase
 Urokinase
 Anticoagulants
 Heparins
 Unfractionated Heparin
 Low Molecular Weight Heparin (LMWH)
 Ultra-low Molecular Weight Heparin
 Vitamin K Antagonists
 Direct Thrombin Inhibitors

16.  Direct Factor Xa Inhibitors
Global Blood Preparation Market Anti-Thrombotic and Anticoagulants Application
Outlook (Revenue, USD Million, 2012 – 2022)
 Thrombocytosis
 Pulmonary Embolism
 Renal Impairment
 Others
Blood preparation Market Regional Outlook (Revenue, USD Million, 2012 – 2022)
 North America
 U.S.
 Canada
 Europe
 Germany
 France
 UK
 Italy
 Rest of Europe
 Asia Pacific
 Japan
 China
 Rest of Asia Pacific
 Latin America
 Brazil
 Mexico
 Middle East and Africa (MEA)
 South Africa
Ant-ithrombotics and Anticoagulants Regional Outlook (Revenue, USD Million, 2012 – 2022)
 North America
 U.S.
 Canada
 Europe
 Germany
 France
 UK
 Italy
 Asia Pacific

17.  Japan
 China
 Latin America
 Brazil
 Mexico
 Middle East and Africa (MEA)
 South Africa
Browse All Reports of this category @
http://www.grandviewresearch.com/industry/pharmaceuticals
About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-
shelf, customized research reports and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and energy. With a deep-
seated understanding of varied business environments, Grand View Research provides strategic
objective insights.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research
Blog Site: http://www.divog.org/